Celldex Therapeutics (CLDX) Shares Issued (2011 - 2026)

Celldex Therapeutics' Shares Issued history runs 16 years deep, the most recent figure standing at $2.7 million for Q1 2026.

• On a quarterly basis, Shares Issued fell 36.69% year-over-year to $2.7 million in Q1 2026; TTM through Mar 2026 was $2.7 million, a 36.69% decrease from a year earlier, with the FY2025 full-year figure at $9.1 million, up 21.14% from the prior year.
• Shares Issued declined to $2.7 million in Q1 2026 per CLDX's latest filing, from $9.1 million in the prior quarter.
• Across five years, Shares Issued topped out at $9.2 million in Q3 2025 and bottomed at $2.1 million in Q2 2022.
• The 5-year median for Shares Issued is $5.1 million (2022), against an average of $5.4 million.
• Across the five-year window, Shares Issued soared 269.54% in 2025 and plunged 36.69% in 2026, its largest moves.
• Year by year, Shares Issued stood at $5.1 million in 2022, then increased by 25.43% to $6.4 million in 2023, then increased by 18.2% to $7.5 million in 2024, then grew by 21.14% to $9.1 million in 2025, then slumped by 70.66% to $2.7 million in 2026.
• Per Business Quant, the three latest CLDX Shares Issued figures stand at $2.7 million (Q1 2026), $9.1 million (Q4 2025), and $9.2 million (Q3 2025).